|

AL8326 tablets Clinical Trials

2 actively recruiting trials

No change since May 2026

Also known as: AL8326

Pipeline

Phase 3: 1Phase 1/2: 1

Top Sponsors

  • Advenchen Laboratories, LLC1
  • Advenchen Laboratories Nanjing Ltd.1

Indications

Other2 trials

A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.
Phase 1/2
A Phase IIII Study of AL8326 in Small Cell Lung Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.